Reported Oct 6, 2021 · Terminated
Ruzurgi (amifampridine) Tablets 10 mg, packaged in 100-count bottles, Rx only, Manufactured by: Jacobus Pharmaceutical…
Jacobus Pharmaceutical Company Inc.
High riskUsing this product could cause serious injury, illness or death — stop using it now.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Jacobus Pharmaceutical Company Inc. · Industrial Research Laboratory Building · Plainsboro, NJ · 08536
Is this the product you have?
Ruzurgi (amifampridine) Tablets 10 mgpackaged in 100-count bottlesRx only
- Manufactured byJacobus Pharmaceutical Company, Inc, P.O. Box 5290, Princeton, New Jersey 08540, NDC 49938-110-01
- Lot codes and dates
Lot #: 1803818039Exp 03/202318079Exp 05/2023
- Amount recalled
- 2,324 bottles
Why it was recalled
Stop using this product now
Microbial contamination of non-sterile products: Firm's testing found lots to exceed specification for aerobic bacteria, yeast, and mold counts.
Using this product could cause serious injury, illness or death — stop using it now.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Jacobus Pharmaceutical Company Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.